Pharmalittle

Pharmalot Damian Garde

Pharmalittle: GSK picks its first female CFO; Pfizer advances Omicron booster for kids

Pharmalot Ed Silverman

Pharmalittle: U.S. drug net prices fell nearly 8% in the second quarter; FDA panel favors fecal-based therapy for bacterial infections

Pharmalot Ed Silverman

Pharmalittle: Biogen ALS drug trial yields mixed signals; Novartis makes U.S. growth its top priority

Pharmalot Ed Silverman

Pharmalittle: FDA scolds Catalent over quality control at plant making Covid shots; Novartis will ask SCOTUS to protect a key patent

Pharmalot Jonathan Wosen

Pharmalittle: An emerging star in biotech investment; U.S. government expected to stop paying for Covid shots next year

Pharmalot Allison DeAngelis

Pharmalittle: FDA expected to authorize new Covid-19 boosters; Biden administration signs a deal to support monkeypox vaccine manufacturing

Pharmalot Allison DeAngelis

Pharmalittle: The ‘godfather’ of biotech trying to save Biogen; pharma companies grapple with ADHD drug shortages

Pharmalot Ed Silverman

Pharmalittle: Senate bill would allow insulin makers to lock in profits; GSK, Novartis pledge funds for diseases that mostly affect the poor

Pharmalot Ed Silverman

Pharmalittle: U.K. inks $1.2 billion deal with Moderna for vaccine center; Top Biocon exec arrested in bribery scandal

Pharmalot Ed Silverman

Pharmalittle: Medicare could have saved billions if it paid what Cuban charges; India’s drug controller accused of taking bribe

Pharmalot Ed Silverman

Pharmalittle: Merck is eyeing Seagen to beef up its cancer drug portfolio; Lawmakers want GAO to probe PBMs

Pharmalot Ed Silverman

Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge

Pharmalot Ed Silverman

Pharmalittle: Califf admits Alzheimer’s drug controversy has hurt expert trust in FDA; House passes bill to lower insulin costs

Pharmalot Elizabeth Cooney

Pharmalittle: Advisory panel narrowly votes down ALS drug; Vertex looks to advance experimental pain drug

Pharmalot Ed Silverman

Pharmalittle: Insurers balk at opioid payouts to drugmakers and wholesalers; AbbVie settles another Humira biosimilar lawsuit

Pharmalot Ed Silverman

Pharmalittle: Francis Collins to step down as NIH director; Research confirms decline in Pfizer vaccine protection against ‘breakthrough’ infection

Pharmalot Ed Silverman

Pharmalittle: J&J to seek emergency use of Covid-19 vaccine booster; Pfizer loses legal battle over Medicare co-pay programs

Pharmalot Ed Silverman

Pharmalittle: CDC director overrules panel and recommends Pfizer shot for at-risk workers; DOD watchdog faults military over pharma supply chain issues

Pharmalot Ed Silverman

Pharmalittle: Biogen yanks Alzheimer’s paper from JAMA over edits; Pfizer sees $33.5 billion in Covid-19 vax sales

Pharmalot Ed Silverman

Pharmalittle: Pharma lobbies Congress on global tax proposal; the FDA doc at center of Aduhelm controversy

Pharmalot Ed Silverman

Pharmalittle: A race to develop Covid-19 pills is underway; Russian trolls target Pfizer vaccine

Pharmalot Elizabeth Cooney

Pharmalittle: Biogen’s ‘symptom quiz’ for Aduhelm draws fire; most U.S. clinical trials flunk transparency rules

Pharmalot Ed Silverman

Pharmalittle: Biogen defends its controversial Alzheimer’s drug; critics pan Pfizer plan for Covid-19 shot production in Africa

Pharmalot Ed Silverman

Pharmalittle: Pfizer cuts deal for Covid-19 shot to be partially made in South Africa; wholesalers to pay $1.1b to NY to settle opioid suit

Pharmalot Ed Silverman

pharmalittle

Most Read

Pharmalittle: Haleon argues it’s not liable for any Zantac claims; FDA steps up surprise inspections in India

Pharmalittle: Advances in treating the sickest Covid patients have stalled; Moderna aids WHO effort to develop mRNA coronavirus shots

Pharmalittle: Swiss authorities probe Novartis over patent used to block rivals; Medicare underserves older Americans with opioid use disorder

Pharmalittle: Pharma pursues the ‘dream’ of online prescribing; EC chief under fire over Pfizer vaccine contract

Pharmalittle: Biden picks biotech exec to lead new biomedical research agency; FDA to hold meeting for OTC birth control pill

Pharmalittle: FDA approves new type of psoriasis drug; U.S. starts late-stage trial to test an antiviral against monkeypox

Pharmalittle: Illumina faces more challenges after winning FTC case; Novo Nordisk buys Forma Therapeutics

Pharmalittle: FDA authorizes new Covid boosters; a setback for federal efforts to regulate stem cell clinics

All Coverage

Pharmalittle: GSK picks its first female CFO; Pfizer advances Omicron booster for kids

Pharmalittle: U.S. drug net prices fell nearly 8% in the second quarter; FDA panel favors fecal-based therapy for bacterial infections

Pharmalittle: Biogen ALS drug trial yields mixed signals; Novartis makes U.S. growth its top priority

Pharmalittle: FDA scolds Catalent over quality control at plant making Covid shots; Novartis will ask SCOTUS to protect a key patent

Pharmalittle: An emerging star in biotech investment; U.S. government expected to stop paying for Covid shots next year

Pharmalittle: FDA expected to authorize new Covid-19 boosters; Biden administration signs a deal to support monkeypox vaccine manufacturing

Pharmalittle: The ‘godfather’ of biotech trying to save Biogen; pharma companies grapple with ADHD drug shortages

Pharmalittle: Senate bill would allow insulin makers to lock in profits; GSK, Novartis pledge funds for diseases that mostly affect the poor

Pharmalittle: U.K. inks $1.2 billion deal with Moderna for vaccine center; Top Biocon exec arrested in bribery scandal

Pharmalittle: Medicare could have saved billions if it paid what Cuban charges; India’s drug controller accused of taking bribe

Pharmalittle: Merck is eyeing Seagen to beef up its cancer drug portfolio; Lawmakers want GAO to probe PBMs

Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge

Pharmalittle: Califf admits Alzheimer’s drug controversy has hurt expert trust in FDA; House passes bill to lower insulin costs

Pharmalittle: Advisory panel narrowly votes down ALS drug; Vertex looks to advance experimental pain drug

Pharmalittle: Insurers balk at opioid payouts to drugmakers and wholesalers; AbbVie settles another Humira biosimilar lawsuit

Pharmalittle: Francis Collins to step down as NIH director; Research confirms decline in Pfizer vaccine protection against ‘breakthrough’ infection

Pharmalittle: J&J to seek emergency use of Covid-19 vaccine booster; Pfizer loses legal battle over Medicare co-pay programs

Pharmalittle: CDC director overrules panel and recommends Pfizer shot for at-risk workers; DOD watchdog faults military over pharma supply chain issues

Pharmalittle: Biogen yanks Alzheimer’s paper from JAMA over edits; Pfizer sees $33.5 billion in Covid-19 vax sales

Pharmalittle: Pharma lobbies Congress on global tax proposal; the FDA doc at center of Aduhelm controversy

Pharmalittle: A race to develop Covid-19 pills is underway; Russian trolls target Pfizer vaccine

Pharmalittle: Biogen’s ‘symptom quiz’ for Aduhelm draws fire; most U.S. clinical trials flunk transparency rules

Pharmalittle: Biogen defends its controversial Alzheimer’s drug; critics pan Pfizer plan for Covid-19 shot production in Africa

Pharmalittle: Pfizer cuts deal for Covid-19 shot to be partially made in South Africa; wholesalers to pay $1.1b to NY to settle opioid suit

Pharmalittle: Pfizer seeks full FDA approval for its Covid-19 vaccine; CT attorney general calls some Sacklers ‘entitled thugs’

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day